Article Details
Retrieved on: 2024-06-06 13:58:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Reports Findings Show LIXTE's Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System. June 06, 2024 at 08:30 ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here